Testosterone replacement therapy in a patient with synchronous tumors including prostate cancer and hypogonadism after bilateral orchiectomy

Czech version

Authors: Marek Broul ^1,2; Lucie Radovnická ³; Jan Schraml ⁴; Martin Hlavička ⁴; Maksim Falion ⁴; Filip Cihlář ⁵; Libor Zámečník ^6,7
Authors‘ workplace: Sexuologické oddělení, Krajská zdravotní, a s – Masarykova nemocnice v Ústí nad Labem, o z ¹; Urologické oddělení, Krajská zdravotní, a s – Nemocnice Litoměřice, o z ²; Klinika urologie a robotické chirurgie Fakulty zdravotnických studií Univerzity J E Purkyně v Ústí, nad Labem a Krajské zdravotní, a s – Masarykovy nemocnice v Ústí nad Labem, o z ⁴; Radiologická klinika Fakulty zdravotnických studií Univerzity J E Purkyně v Ústí nad Labem, a Krajské zdravotní, a s – Masarykovy nemocnice v Ústí nad Labem, o z ⁵; Urologická klinika VFN a 1 LF UK Praha, Sexuologický ústav VFN Praha ⁶; Interní oddělení, Krajská zdravotní, a s – Masarykova nemocnice v Ústí nad Labem, o z ⁷
Published in: Ces Urol 2023; 27(3): 170-175
Category: Case reports
doi: https://doi.org/10.48095/cccu2023015

Overview

We present a case report of a patient who vis ited a physician because of chronic testicular pain During the investigation, he was found to have two synchronous tumors –⁠ carcinoma of the kidney and prostate Both tumors were successfully removed He had to undergo a bilateral orchiectomy in the follow‑up due to a suspicious finding in his testicles For secondary hypogonadism, we started testos terone replacement therapy after discussion with the patient Due to his prostate cancer, ongoing medical care and close follow‑up including DRE (digital rectal examination), PSA, testosterone, liver function tests, blood counts, ultrasounds and CT scans are necessary Testosterone replacement in patients after treatment for prostate cancer is a possible and safe treatment of secondary hypog onadism under certain conditions